Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1962 1
1965 1
1970 1
1972 3
1973 2
1974 1
1975 3
1976 6
1977 8
1978 5
1979 15
1980 11
1981 10
1982 13
1983 18
1984 17
1985 25
1986 21
1987 26
1988 17
1989 20
1990 25
1991 34
1992 43
1993 39
1994 35
1995 51
1996 42
1997 42
1998 59
1999 50
2000 58
2001 69
2002 92
2003 117
2004 148
2005 209
2006 205
2007 226
2008 282
2009 284
2010 410
2011 453
2012 534
2013 639
2014 706
2015 823
2016 839
2017 919
2018 1056
2019 1221
2020 1561
2021 1804
2022 2296
2023 2208
2024 2489
2025 2911
2026 47

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20,905 results

Results by year

Filters applied: . Clear all
Page 1
Thiotepa and Busulfan Combined With Cyclophosphamide Conditioning Regimen Plus Maintenance Therapy Improved the Disease-Free Survival of Patients With Relapsed/Refractory Hematologic Malignancies After Undergoing Allogeneic Transplantation.
Chen S, Cui R, He Y, Ma Q, Zhang R, Chen X, Cao W, Wei J, Yang D, Pang A, Feng S, Han M, Zhai W, Jiang E. Chen S, et al. Among authors: wei j. Hematol Oncol. 2026 Jan;44(1):e70138. doi: 10.1002/hon.70138. Hematol Oncol. 2026. PMID: 41396587
Venetoclax and Homoharringtonine-Based Therapy Exhibited a Striking Response in Refractory/Relapsed Early T-Cell Precursor Acute Lymphoblastic Leukemia.
Zhang X, Zhou H, Mao L, Lou Y, Shen L, Lu Y, Liu Z, Tong X, Zhang A, Liu T, Zhang N, Ye X, Wei J, Luo M, Wang S, Bai Q, Hou J, Liu Q, Tong H, Jin J, Yu W. Zhang X, et al. Among authors: wei j. MedComm (2020). 2025 Dec 12;6(12):e70549. doi: 10.1002/mco2.70549. eCollection 2025 Dec. MedComm (2020). 2025. PMID: 41394964 Free PMC article.
Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial.
Cao Y, Li Q, Guo W, Xu M, Fang K, Wang F, Zhang R, Li L, Wei J, Liu Z, Liang C, Zhai W, Ma Q, Chen X, Cao W, Yang D, He Y, Pang A, Feng S, Han M, Sun J, Jiang E. Cao Y, et al. Among authors: wei j. Front Immunol. 2025 Nov 28;16:1626775. doi: 10.3389/fimmu.2025.1626775. eCollection 2025. Front Immunol. 2025. PMID: 41394817 Free PMC article. Clinical Trial.
20,905 results
You have reached the last available page of results. Please see the User Guide for more information.